IVD Infectious Diseases Market, Global Outlook and Forecast 2023-2028

Report ID: 1372313 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 IVD Infectious Diseases Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global IVD Infectious Diseases Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global IVD Infectious Diseases Overall Market Size
    2.1 Global IVD Infectious Diseases Market Size: 2021 VS 2028
    2.2 Global IVD Infectious Diseases Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top IVD Infectious Diseases Players in Global Market
    3.2 Top Global IVD Infectious Diseases Companies Ranked by Revenue
    3.3 Global IVD Infectious Diseases Revenue by Companies
    3.4 Top 3 and Top 5 IVD Infectious Diseases Companies in Global Market, by Revenue in 2021
    3.5 Global Companies IVD Infectious Diseases Product Type
    3.6 Tier 1, Tier 2 and Tier 3 IVD Infectious Diseases Players in Global Market
        3.6.1 List of Global Tier 1 IVD Infectious Diseases Companies
        3.6.2 List of Global Tier 2 and Tier 3 IVD Infectious Diseases Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global IVD Infectious Diseases Market Size Markets, 2021 & 2028
        4.1.2 Immunochemistry
        4.1.3 Molecular Diagnostics
    4.2 By Type - Global IVD Infectious Diseases Revenue & Forecasts
        4.2.1 By Type - Global IVD Infectious Diseases Revenue, 2017-2022
        4.2.2 By Type - Global IVD Infectious Diseases Revenue, 2023-2028
        4.2.3 By Type - Global IVD Infectious Diseases Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global IVD Infectious Diseases Market Size, 2021 & 2028
        5.1.2 Clinical Laboratories
        5.1.3 Diagnostic Centers
    5.2 By Application - Global IVD Infectious Diseases Revenue & Forecasts
        5.2.1 By Application - Global IVD Infectious Diseases Revenue, 2017-2022
        5.2.2 By Application - Global IVD Infectious Diseases Revenue, 2023-2028
        5.2.3 By Application - Global IVD Infectious Diseases Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global IVD Infectious Diseases Market Size, 2021 & 2028
    6.2 By Region - Global IVD Infectious Diseases Revenue & Forecasts
        6.2.1 By Region - Global IVD Infectious Diseases Revenue, 2017-2022
        6.2.2 By Region - Global IVD Infectious Diseases Revenue, 2023-2028
        6.2.3 By Region - Global IVD Infectious Diseases Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America IVD Infectious Diseases Revenue, 2017-2028
        6.3.2 US IVD Infectious Diseases Market Size, 2017-2028
        6.3.3 Canada IVD Infectious Diseases Market Size, 2017-2028
        6.3.4 Mexico IVD Infectious Diseases Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe IVD Infectious Diseases Revenue, 2017-2028
        6.4.2 Germany IVD Infectious Diseases Market Size, 2017-2028
        6.4.3 France IVD Infectious Diseases Market Size, 2017-2028
        6.4.4 U.K. IVD Infectious Diseases Market Size, 2017-2028
        6.4.5 Italy IVD Infectious Diseases Market Size, 2017-2028
        6.4.6 Russia IVD Infectious Diseases Market Size, 2017-2028
        6.4.7 Nordic Countries IVD Infectious Diseases Market Size, 2017-2028
        6.4.8 Benelux IVD Infectious Diseases Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia IVD Infectious Diseases Revenue, 2017-2028
        6.5.2 China IVD Infectious Diseases Market Size, 2017-2028
        6.5.3 Japan IVD Infectious Diseases Market Size, 2017-2028
        6.5.4 South Korea IVD Infectious Diseases Market Size, 2017-2028
        6.5.5 Southeast Asia IVD Infectious Diseases Market Size, 2017-2028
        6.5.6 India IVD Infectious Diseases Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America IVD Infectious Diseases Revenue, 2017-2028
        6.6.2 Brazil IVD Infectious Diseases Market Size, 2017-2028
        6.6.3 Argentina IVD Infectious Diseases Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa IVD Infectious Diseases Revenue, 2017-2028
        6.7.2 Turkey IVD Infectious Diseases Market Size, 2017-2028
        6.7.3 Israel IVD Infectious Diseases Market Size, 2017-2028
        6.7.4 Saudi Arabia IVD Infectious Diseases Market Size, 2017-2028
        6.7.5 UAE IVD Infectious Diseases Market Size, 2017-2028
7 Players Profiles
    7.1 BD
        7.1.1 BD Corporate Summary
        7.1.2 BD Business Overview
        7.1.3 BD IVD Infectious Diseases Major Product Offerings
        7.1.4 BD IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.1.5 BD Key News
    7.2 BioMerieux
        7.2.1 BioMerieux Corporate Summary
        7.2.2 BioMerieux Business Overview
        7.2.3 BioMerieux IVD Infectious Diseases Major Product Offerings
        7.2.4 BioMerieux IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.2.5 BioMerieux Key News
    7.3 Abbott
        7.3.1 Abbott Corporate Summary
        7.3.2 Abbott Business Overview
        7.3.3 Abbott IVD Infectious Diseases Major Product Offerings
        7.3.4 Abbott IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.3.5 Abbott Key News
    7.4 Quidel
        7.4.1 Quidel Corporate Summary
        7.4.2 Quidel Business Overview
        7.4.3 Quidel IVD Infectious Diseases Major Product Offerings
        7.4.4 Quidel IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.4.5 Quidel Key News
    7.5 Gen-Probe
        7.5.1 Gen-Probe Corporate Summary
        7.5.2 Gen-Probe Business Overview
        7.5.3 Gen-Probe IVD Infectious Diseases Major Product Offerings
        7.5.4 Gen-Probe IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.5.5 Gen-Probe Key News
    7.6 Abbott
        7.6.1 Abbott Corporate Summary
        7.6.2 Abbott Business Overview
        7.6.3 Abbott IVD Infectious Diseases Major Product Offerings
        7.6.4 Abbott IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.6.5 Abbott Key News
    7.7 Danaher
        7.7.1 Danaher Corporate Summary
        7.7.2 Danaher Business Overview
        7.7.3 Danaher IVD Infectious Diseases Major Product Offerings
        7.7.4 Danaher IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.7.5 Danaher Key News
    7.8 Sysmex
        7.8.1 Sysmex Corporate Summary
        7.8.2 Sysmex Business Overview
        7.8.3 Sysmex IVD Infectious Diseases Major Product Offerings
        7.8.4 Sysmex IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.8.5 Sysmex Key News
    7.9 Orasure
        7.9.1 Orasure Corporate Summary
        7.9.2 Orasure Business Overview
        7.9.3 Orasure IVD Infectious Diseases Major Product Offerings
        7.9.4 Orasure IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.9.5 Orasure Key News
    7.10 Hologic
        7.10.1 Hologic Corporate Summary
        7.10.2 Hologic Business Overview
        7.10.3 Hologic IVD Infectious Diseases Major Product Offerings
        7.10.4 Hologic IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.10.5 Hologic Key News
    7.11 Cepheid
        7.11.1 Cepheid Corporate Summary
        7.11.2 Cepheid Business Overview
        7.11.3 Cepheid IVD Infectious Diseases Major Product Offerings
        7.11.4 Cepheid IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.11.5 Cepheid Key News
    7.12 Qiagen
        7.12.1 Qiagen Corporate Summary
        7.12.2 Qiagen Business Overview
        7.12.3 Qiagen IVD Infectious Diseases Major Product Offerings
        7.12.4 Qiagen IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.12.5 Qiagen Key News
    7.13 Roche Diagnostics
        7.13.1 Roche Diagnostics Corporate Summary
        7.13.2 Roche Diagnostics Business Overview
        7.13.3 Roche Diagnostics IVD Infectious Diseases Major Product Offerings
        7.13.4 Roche Diagnostics IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.13.5 Roche Diagnostics Key News
    7.14 Siemens Healthcare
        7.14.1 Siemens Healthcare Corporate Summary
        7.14.2 Siemens Healthcare Business Overview
        7.14.3 Siemens Healthcare IVD Infectious Diseases Major Product Offerings
        7.14.4 Siemens Healthcare IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.14.5 Siemens Healthcare Key News
    7.15 Bio-Rad Laboratories
        7.15.1 Bio-Rad Laboratories Corporate Summary
        7.15.2 Bio-Rad Laboratories Business Overview
        7.15.3 Bio-Rad Laboratories IVD Infectious Diseases Major Product Offerings
        7.15.4 Bio-Rad Laboratories IVD Infectious Diseases Revenue in Global Market (2017-2022)
        7.15.5 Bio-Rad Laboratories Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. IVD Infectious Diseases Market Opportunities & Trends in Global Market
    Table 2. IVD Infectious Diseases Market Drivers in Global Market
    Table 3. IVD Infectious Diseases Market Restraints in Global Market
    Table 4. Key Players of IVD Infectious Diseases in Global Market
    Table 5. Top IVD Infectious Diseases Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global IVD Infectious Diseases Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global IVD Infectious Diseases Revenue Share by Companies, 2017-2022
    Table 8. Global Companies IVD Infectious Diseases Product Type
    Table 9. List of Global Tier 1 IVD Infectious Diseases Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 IVD Infectious Diseases Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global IVD Infectious Diseases Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - IVD Infectious Diseases Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - IVD Infectious Diseases Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global IVD Infectious Diseases Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - IVD Infectious Diseases Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - IVD Infectious Diseases Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global IVD Infectious Diseases Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global IVD Infectious Diseases Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global IVD Infectious Diseases Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America IVD Infectious Diseases Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America IVD Infectious Diseases Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe IVD Infectious Diseases Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe IVD Infectious Diseases Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia IVD Infectious Diseases Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia IVD Infectious Diseases Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America IVD Infectious Diseases Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America IVD Infectious Diseases Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa IVD Infectious Diseases Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa IVD Infectious Diseases Revenue, (US$, Mn), 2023-2028
    Table 30. BD Corporate Summary
    Table 31. BD IVD Infectious Diseases Product Offerings
    Table 32. BD IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 33. BioMerieux Corporate Summary
    Table 34. BioMerieux IVD Infectious Diseases Product Offerings
    Table 35. BioMerieux IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 36. Abbott Corporate Summary
    Table 37. Abbott IVD Infectious Diseases Product Offerings
    Table 38. Abbott IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 39. Quidel Corporate Summary
    Table 40. Quidel IVD Infectious Diseases Product Offerings
    Table 41. Quidel IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 42. Gen-Probe Corporate Summary
    Table 43. Gen-Probe IVD Infectious Diseases Product Offerings
    Table 44. Gen-Probe IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 45. Abbott Corporate Summary
    Table 46. Abbott IVD Infectious Diseases Product Offerings
    Table 47. Abbott IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 48. Danaher Corporate Summary
    Table 49. Danaher IVD Infectious Diseases Product Offerings
    Table 50. Danaher IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 51. Sysmex Corporate Summary
    Table 52. Sysmex IVD Infectious Diseases Product Offerings
    Table 53. Sysmex IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 54. Orasure Corporate Summary
    Table 55. Orasure IVD Infectious Diseases Product Offerings
    Table 56. Orasure IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 57. Hologic Corporate Summary
    Table 58. Hologic IVD Infectious Diseases Product Offerings
    Table 59. Hologic IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 60. Cepheid Corporate Summary
    Table 61. Cepheid IVD Infectious Diseases Product Offerings
    Table 62. Cepheid IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 63. Qiagen Corporate Summary
    Table 64. Qiagen IVD Infectious Diseases Product Offerings
    Table 65. Qiagen IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 66. Roche Diagnostics Corporate Summary
    Table 67. Roche Diagnostics IVD Infectious Diseases Product Offerings
    Table 68. Roche Diagnostics IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 69. Siemens Healthcare Corporate Summary
    Table 70. Siemens Healthcare IVD Infectious Diseases Product Offerings
    Table 71. Siemens Healthcare IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
    Table 72. Bio-Rad Laboratories Corporate Summary
    Table 73. Bio-Rad Laboratories IVD Infectious Diseases Product Offerings
    Table 74. Bio-Rad Laboratories IVD Infectious Diseases Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. IVD Infectious Diseases Segment by Type in 2021
    Figure 2. IVD Infectious Diseases Segment by Application in 2021
    Figure 3. Global IVD Infectious Diseases Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global IVD Infectious Diseases Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global IVD Infectious Diseases Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2021
    Figure 8. By Type - Global IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 9. By Application - Global IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 10. By Region - Global IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 11. By Country - North America IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 12. US IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 16. Germany IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 17. France IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 24. China IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 28. India IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 30. Brazil IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa IVD Infectious Diseases Revenue Market Share, 2017-2028
    Figure 33. Turkey IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE IVD Infectious Diseases Revenue, (US$, Mn), 2017-2028
    Figure 37. BD IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. BioMerieux IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Abbott IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Quidel IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Gen-Probe IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Abbott IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Danaher IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Sysmex IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Orasure IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Hologic IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Cepheid IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Qiagen IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Roche Diagnostics IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Siemens Healthcare IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Bio-Rad Laboratories IVD Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
109
Frequently Asked Questions
IVD Infectious Diseases Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
IVD Infectious Diseases Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
IVD Infectious Diseases Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports